Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
NCT ID: NCT04708912
Last Updated: 2021-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-12-15
2021-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442
Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System
NCT04860895
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522
Antibiotics Use and Carriage of Methicillin-resistant Staphylococci in Community Patients
NCT01489878
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers
NCT04659941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In vitro cytokines production will be studied and compared in Nill (No antigens) and Mitojen (Cocktail of antigens) pre-prepared test tubes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Mild-Moderate COVID-19
Observation
The study parameters will be obtained at the time of recuirement (Basal)
2
Severe COVID-19
Observation
The study parameters will be obtained at the time of recuirement (Basal)
3
Convalsent (COVID-19)
Observation
The study parameters will be obtained at the time of recuirement (Basal)
4
Healthy persons
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
The study parameters will be obtained at the time of recuirement (Basal)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Using of medications that affect the results of study parameters
* Presence of malignancy or tuberculosis
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Başakşehir Çam & Sakura City Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Hursitoglu
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Hursitoglu, MD
Role: PRINCIPAL_INVESTIGATOR
Basaksehir Cam and sakura Sehir Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bakirkoy Dr.sadi Konuk Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Bakirkoy Dr.sadi Konuk Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Microbiota and viral infections
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8796
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.